Summery outlook for lrcx

**Lam Research Corporation (LRCX) faces a mixed outlook with several factors influencing its performance:** 1. **Technical Indicators**: The stock's technical outlook is bearish in the short to intermediate term, with signs of weakness and resistance levels above the current price. However, the long-term trend remains strong, and support levels are in place. |Ticker|Name|Date|Closing Price|Support Level|Resistance Level|code|market_code| |---|---|---|---|---|---|---|---| |LRCX.O|Lam Research|20241127|71.57|70.4200|72.8700|LRCX|185| 2. **Moving Averages**: The stock is trading below its 5-day, 10-day, and 50-day moving averages, which suggests a bearish trend in the short term. But the 50-day moving average is significantly higher than the current price, indicating a potential for the stock to increase in value. |Ticker|Name|Date|Moving Average|code|market_code| |---|---|---|---|---|---| |LRCX.O|Lam Research|20241127|72.7480|LRCX|185| 3. **RSI and MACD**: The RSI is at 40.62, which is neither in the oversold nor in the overbought territory. The MACD is at 0.01, which could suggest a potential upward momentum if the stock price were to increase. |Ticker|Name|Date|RSI|KDJ|MACD|code|market_code| |---|---|---|---|---|---|---|---| |LRCX.O|Lam Research|20241127|40.6231|63.5069|0.0072|LRCX|185| 4. **Analyst Consensus**: The consensus rating is a "Strong Buy" with an average price target of $518.17, which is a significant premium to the current price, indicating optimism about the stock's future performance. 5. **Fundamental Analysis**: The P/E ratio is 22.7, the P/B ratio is 10.87, and the P/S ratio is 5.52, which are all within reasonable ranges, suggesting that the stock may be fairly valued. The net profit margin is 26.79%, and the revenue growth rate is 19.7%, indicating a healthy profitability and growth. |Ticker|Name|Date|P/E(TTM)|code|market_code| |---|---|---|---|---|---| |LRCX.O|Lam Research|20240102|28.444378|LRCX|185| |LRCX.O|Lam Research|20240103|27.974797|LRCX|185| |LRCX.O|Lam Research|20240104|27.752724|LRCX|185| |LRCX.O|Lam Research|20240105|27.802832|LRCX|185| |LRCX.O|Lam Research|20240108|28.742753|LRCX|185| |LRCX.O|Lam Research|20240109|28.547633|LRCX|185| |LRCX.O|Lam Research|20240110|28.459183|LRCX|185| |LRCX.O|Lam Research|20240111|28.858156|LRCX|185| |LRCX.O|Lam Research|20240112|28.838036|LRCX|185| |LRCX.O|Lam Research|20240116|28.893839|LRCX|185| |Ticker|Name|Date|Price to Book Ratio|code|market_code| |---|---|---|---|---|---| |LRCX.O|Lam Research|20240102|12.271367720722276|LRCX|185| |LRCX.O|Lam Research|20240104|11.972976796030485|LRCX|185| |LRCX.O|Lam Research|20240105|11.994594579817157|LRCX|185| |LRCX.O|Lam Research|20240108|12.400091796906551|LRCX|185| |LRCX.O|Lam Research|20240109|12.315913457009964|LRCX|185| |LRCX.O|Lam Research|20240110|12.277754793204704|LRCX|185| |LRCX.O|Lam Research|20240111|12.449878208051615|LRCX|185| |LRCX.O|Lam Research|20240112|12.441198340319087|LRCX|185| |LRCX.O|Lam Research|20240116|12.465272690445154|LRCX|185| |LRCX.O|Lam Research|20240117|12.330325312867746|LRCX|185| |Ticker|Name|Date|P/S|code|market_code| |---|---|---|---|---|---| |LRCX.O|Lam Research|20240102|7.090033549086719|LRCX|185| |LRCX.O|Lam Research|20240103|6.9729860180548195|LRCX|185| |LRCX.O|Lam Research|20240104|6.917632092708286|LRCX|185| |LRCX.O|Lam Research|20240105|6.9301222091967345|LRCX|185| |LRCX.O|Lam Research|20240108|7.164406515449754|LRCX|185| |LRCX.O|Lam Research|20240109|7.115770758820492|LRCX|185| |LRCX.O|Lam Research|20240110|7.093723810776488|LRCX|185| |LRCX.O|Lam Research|20240111|7.193171632211029|LRCX|185| |LRCX.O|Lam Research|20240112|7.188156661196728|LRCX|185| |LRCX.O|Lam Research|20240116|7.202066109104318|LRCX|185| 6. **Financial Health**: The company has a strong net income of $1.12 billion and a positive free cash flow of $1.7 billion, which are positive indicators of financial health. |Ticker|Name|Date|Total Revenue|Net Profit Margin|code|market_code| |---|---|---|---|---|---|---| |LRCX.O|Lam Research|2024 Q2|3.758259E9|25.4362|LRCX|185| |LRCX.O|Lam Research|2024 Q3|3.793558E9|25.4443|LRCX|185| |LRCX.O|Lam Research|2024 Q4|3.871507E9|25.6805|LRCX|185| |LRCX.O|Lam Research|2025 Q1|4.167976E9|26.7862|LRCX|185| |Ticker|Name|Date|Net Income|code|market_code| |---|---|---|---|---|---| |LRCX.O|Lam Research|2024 Q2|9.54266E8|LRCX|185| |LRCX.O|Lam Research|2024 Q3|9.65826E8|LRCX|185| |LRCX.O|Lam Research|2024 Q4|1.020282E9|LRCX|185| |LRCX.O|Lam Research|2025 Q1|1.116444E9|LRCX|185| 7. **Market Sentiment**: Despite the positive fundamentals, the stock has underperformed the broader market and has seen a decline of 10.4% year-to-date. Additionally, there is bearish sentiment in the short term, with resistance levels and a downward trend in the daily chart. 8. **Strategic Position**: Lam Research is strategically positioned in the semiconductor industry, with specialized technology that enables the deposition of specialized films on silicon wafers and the precision etching of these films to craft intricate circuit designs. This positions it well for growth in AI and HPC markets. In conclusion, while the technical indicators and recent performance show some bearish signals, the strong analyst consensus, positive fundamental analysis, and strategic industry position suggest an overall positive outlook for Lam Research. Investors should consider their risk tolerance and investment horizon, as the stock may exhibit volatility in the short term due to the bearish technical outlook.